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Abstract There is increasing concern that sugar consumption
may be linked to the development of metabolic and cardiovas-
cular diseases. There is indeed strong evidence that consump-
tion of energy-dense sugary beverages and foods is associated
with increased energy intake and body weight gain over time.
It is further proposed that the fructose component of sugars
may exert specific deleterious effects due to its propension to
stimulate hepatic glucose production and de novo lipogenesis.
Excess fructose and energy intake may be associated with
visceral obesity, intrahepatic fat accumulation, and high
fasting and postprandial blood triglyceride concentrations.
Additional effects of fructose on blood uric acid and sympa-
thetic nervous system activity have also been reported, but
their link with metabolic and cardiovascular diseases remains
hypothetical. There is growing evidence that fructose at phys-
iologically consumed doses may exert important effects on
kidney function. Whether this is related to the development
of high blood pressure and cardiovascular diseases remains to
be further assessed.
Keywords Fructose and cardiovascular disease . Sugars and
cardiovascular disease .Metabolic disease and sugar .Visceral
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Introduction
Obesity prevalence was low inWestern societies and virtually
absent in most South-American, African, and Asian countries
at the beginning of the twentieth century. The number of in-
dividuals overweight or obese (i.e., body mass index
≥25 kg m−2) has however increased dramatically since then,
to presently affect close to 40 % of the population worldwide
[1]. This augmentation closely paralleled rises in the preva-
lence of coronary heart diseases, hypertension, and stroke [2].
The development of obesity results from a long-lasting
imbalance between energy intake and energy expenditure
and may occur following the excess consumption of any
energy-containing nutrient. There has however been a grow-
ing concern that the deposition of body fat may be particularly
favored by dietary sugars, that would at first sight appear at
odds with the recommendations to consume at least five daily
servings of fruits and vegetables. Yet, these adverse health
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effects were specifically assigned to Bfree^ sugars, defined as
Bmono- and disaccharides added to foods by themanufacturer,
cook, or consumer, plus sugars naturally present in honey,
syrups, and fruit juices^ [3]. Collectively, free sugars are esti-
mated to represent ≈20 % of daily energy intake in western-
ized countries, mostly as mixtures of glucose and fructose [4].
Why May Fructose Specifically Contribute
to Cardiometabolic Risk?
Suspicions on fructose were initially raised by observational
studies showing associations between cardiometabolic dis-
eases and consumption of fructose-containing sugars (i.e., su-
crose, high-fructose corn-syrup, and fruit juices) but not with
lactose (a glucose-galactose dimer). These considerations
were also confirmed by several pre-clinical and clinical studies
globally showing that dietary fructose can induce several met-
abolic alterations bearing close similarity with the metabolic
syndrome [5, 6]. The existence of direct causal link between
fructose intake and the development of metabolic and cardio-
vascular diseases, however, remains also disputed [7, 8].
Unlike glucose and fatty acids that are key energy sub-
strates and are metabolizable by most cells, fructose cannot
be used as such and requires to be pre-processed in splanchnic
organs [9]. In the liver, fructose undergoes a three-step inter-
mediate metabolism (i.e., Bfructolysis^) generating trioses-
phosphates that join the glycolysis pathway. Since the main
phosphorylating enzyme governing this sequence
(fructokinase, converting fructose to fructose-1-phosphate) is
unregulated, fructose intake has been proposed to lower he-
patic ATP pools, thus stimulating hepatic nucleotide turnover
and uric acid production [10]. Furthermore, fructose was con-
sidered to induce an overload of trioses phosphates that could
either be converted to glucose, lactate, glycerol or fatty acids,
or be directed to mitochondrial oxidation. The synthesized
products, in turn, could be secreted in the circulation or furnish
liver glycogen and triglycerides pools [11•]. As a remarkable
result of this hepatocentric metabolism, fructose induces very
little insulin secretion. These fructose-induced increases in
hepatic glucose production and VLDL-TG secretion were
proposed by several authors as being early markers of cardio-
metabolic diseases [5, 6]. In the next sections, we will discuss
how fructose could specifically increase cardiovascular risk
by promoting visceral and intrahepatic fat deposition,
hypertriglyceridemia, and hypertension.
Effects of Fructose on Visceral and Intrahepatic Fat
Deposition
Results from many large and medium-sized cohort studies
clearly indicate that the consumption of sugar, and more spe-
cifically of sugar-sweetened beverages, is related with weight
gain over time [12•]. This association becomes weaker when
adjusted for total energy intake, however, indicating that it is
confounded by obesity. Of interest, some small-sized short-
term intervention studies noticed that dietary fructose may be
more specifically associated with visceral fat than glucose.
The mechanisms responsible remain to be understood, yet,
particularly since this effect was observed only in males in
one of these trials [13]. If these data were to be replicated in
other well-controlled larger studies, such an effect of fructose
would indeed be a major health concern, given the strong
association between visceral adipose tissue and both insulin
resistance and cardiovascular risk.
The relationship between cardiovascular and/or metabolic
risk and visceral fat depots in general has been recently
reconsidered in favor of a prevailing role of intrahepatic fat.
It is indeed well established that the prevalence of non-
alcoholic fatty liver disease is very high among subjects with
abdominal obesity and insulin resistance. Furthermore, the
study of subgroups of subjects with similar visceral fat mass
but differing intrahepatic fat suggested that ectopic fat depots
in the liver, rather than omental fat, may be directly linked
with insulin resistance and cardiovascular risk [14].
Interestingly, it was observed that switching healthy volun-
teers from a low to a high-fructose diet significantly increased
intrahepatic fat content within a few days [15]. This effect may
be related with the conversion of a portion of fructose carbons
into lipids through hepatic de novo lipogenesis. In this ener-
getically costly anabolic pathway, mitochondrial citrate is first
transported to the cytosol, then converted to acetyl-CoA and
to malonyl-CoA. The latter, in turn, acts as a precursor for the
iterative addition of two-carbon acetate chains to acetyl-CoA,
resulting in the synthesis of palmitate (C16:0). Palmitate can
be elongated to stearate (C18:0) and to fatty acids of longer
carbon backbone by elongases, and both palmitate and stea-
rate can be desaturated to palmitoleate (C16:1) and oleate
(C18:1), respectively (Fig. 1).
The net effect of de novo lipogenesis on cardiovascular risk
remains unclear and could largely depend on factors beyond
the net mass of acetyl-CoA polymerized. The type of synthe-
sized fatty acids may be particularly important, especially
since high concentrations of palmitate have been well-
described to promote atherogenesis. Alternatively, the activa-
tion of ChREBP and specifically of SREBP-1c could limit
palmitate and stearate accumulation by promoting their
desaturation into palmitoleate and oleate by SCD. Oleate, in
turn, was found in vitro to protect against palmitate-induced
lipotoxicity [16]. Consistent with a key role of saturated to
unsaturated fatty acid ratio (SFA:UFA), SCD-deficient mice
are highly insulin-sensitive and resistant to diet-induced
obesity [17]. Similarly, the ratio of dietary fatty acids was
also shown to critically affect carbohydrate-induced steatosis
[18]. How these effects interplay in humans, and how
they alter cardiovascular health could be investigated in
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Inuits, in which specific variants of desaturases and elongases
were recently found [19].
Fructose has been amply documented to stimulate hepatic
de novo lipogenesis more efficiently than glucose, and this
was proposed to account for its role in non-alcoholic fatty liver
disease. Recent short-term intervention studies, however, re-
vealed that hypercaloric high-fructose and high-glucose diets
both increased intrahepatic fat content to the same extent in
healthy human volunteers [15, 20•]. The same was also ob-
served for high-fat hypercaloric diet [21•]. In contrast, the
consumption of weight-maintenance high-fructose diet led to
a moderate stimulation of hepatic de novo lipogenesis [22••,
23•], but neither high-fructose nor high-glucose diets were
associated with increased intrahepatic fat content [20•]. This
suggests that, more than fructose per se, excess energy intake
may be responsible for the development of hepatic steatosis.
Effects of Fructose on Fasting and Postprandial
Triglycerides
Many epidemiological studies indicated a strong association
between sugar intake and blood triglyceride concentrations
[24]. Fructose, in particular, was found in numerous short-
term intervention studies to further increase fasting and
postprandial triglycerides [13, 25] and may also alter choles-
terol metabolism [26].
The mechanisms underlying fructose-induced hypertri-
glyceridemia remain controversial. On one hand [27], the con-
version of fructose carbons into fatty acids by de novo lipo-
genesis may be responsible for both increased hepatic triglyc-
eride synthesis and VLDL-triglyceride secretion, concomi-
tantly enhancing circulating triglycerides appearance [28].
On the other hand, fructose was suggested to impair plasma
clearance of triglyceride-rich lipoproteins, since co-ingested
fructose enhanced the triglyceride response to a mixed meal
[25]. In turn, both processes may vary according to popula-
tion, fructose dose, and co-ingested nutrients.
Since high fasting and postprandial blood triglyceride are
recognized to be independent risk factors for cardiovascular
diseases, their augmentation following fructose intake is con-
sistent with a role of fructose in cardiovascular risk.
Accordingly, when fructose replaced starch in weight-
maintaining controlled diets, it significantly raised blood tri-
glyceride concentrations. Interestingly, these increases were
larger and mainly observed when fructose was administered
as part of hypercaloric diets, suggesting a modulation of this
effect by energy balance. In turn, other factors may be in-
volved, since moderate exercise normalized fasting and
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Fig. 1 Potential roles of fructose-derived de novo lipogenesis on
cardiovascular health. De novo lipogenesis, i.e., synthesis of long-chain
fatty acids from acetyl-coA precursors, can occur following the pre-
respiratory degradation of any nutrients. This pathway is particularly
active during fructose overfeeding experiments, however, and the high
lipogenic potential of fructose is due to (1) an unregulated synthesis of
pyruvate and acetyl-CoA and (2) a stimulation of lipogenic transcription
factors CHREBP and SREBP-1c by intracellular fructose metabolites. In
turn, this stimulation of de novo lipogenesis may be associated with
increased VLDL-triglyceride secretion and intrahepatic fat accumulation.
The outcome of this process may also depend on the ratio of saturated to
unsaturated fatty acids (SFA:UFA) in blood lipids, affected by dietary fat
as well as by the relative activities of the enzymes involved in synthesis
(fatty acid synthase), elongation (elongases), and desaturation (stearoyl-
CoA desaturase) of newly generated fatty acids. Abbreviations: ChREBP
carbohydrate-responsive element-binding protein, SREBP-1c sterol
regulatory element-binding protein 1c, CoA coenzyme A, ACC acetyl-
CoA carboxylase, FAS fatty acid synthase, SCD stearoyl-CoA
desaturases, VLDL-TG triglycerides in very low-density lipoprotein
fraction, SFA:UFA saturated-to-unsaturated fatty acids ratio
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postprandial triglycerides concentrations, even in conditions
of neutral energy balance [23•]. The available data, however,
clearly indicate that fructose-induced hypertriglyceridemia
generally remains within the normal range (i.e., under patho-
logical thresholds), and whether this reflects a normal effect of
fructose [29] or a true risk factor is still debated.
Effects of Fructose on Blood Pressure and Hemodynamics
Recent epidemiological data from large cohort studies show a
strong positive relationship between sugars [24] or fructose
[30] intake and hypertension. Both associations, interestingly,
were markedly attenuated when adjusted for body weight,
suggesting that obesity was an important confounder. Few
short-term intervention studies reported the effects of altering
dietary fructose content on blood pressure. Although most of
them did not report any significant effect of on blood pressure
[13, 31], one study documented a 6 % increase in ambulatory
blood pressure in middle-aged men with the metabolic syn-
drome [32]. Several mechanisms may potentially account for
hypertensive effects of fructose (Fig. 2) [33]:
– Sympathetic Nervous System (SNS) Activation
Carbohydrate ingestion and intravenous infusion of
glucose both increase sympathetic nervous system activ-
ity, the effects of which are highly complex and only
partly elucidated. SNS activity was suspected to be pro-
tective against obesity in some individuals through
allowing energy wasting. Consequently, it has been inten-
sively investigated in studies measuring the concentra-
tions and turnover of norepinephrine [34], as well as
organ-specific microneurography [35]. These reports,
however, resulted in little support of an anti-obesogenic
effect, but demonstrated that SNS activation was much
more complexly orchestrated than previously thought,
and was differentially regulated in various organs.
The functional significance of food-induced sympa-
thetic activation remains largely hypothetical. Glucose
and insulin infusion both increase markers of SNS
activity, and at the same time, stimulate resting energy
expenditure. Since this effect can be partially inhibited
by administration of beta-adrenergic antagonists [36],
SNS was considered to be involved in adaptive thermo-
genesis. Such SNS-mediated heat generation was initially
proposed to mainly occur in brown adipocytes in rodents
[34] and in skeletal muscle in humans [37]. This concept,
however, may need to be revised following demonstra-
tions of brown adipose tissue existence in healthy human
adults [38]. These specialized cells, alike recently discov-
ered Bbeige^ adipocytes [39], can generate heat by
uncoupling mitochondrial respiration fromATP synthesis
and may be active during stressful situations such as cold
exposure or exercise [40]. Whether this is related to food-
induced sympathetic activation and regulation of body
temperature remains speculative, however.
SNS activation varies according to the type of carbo-
hydrate consumed and to the organ considered. Glucose
administration, either intravenous or oral, stimulates mus-
cle sympathetic nerve activity [41]. This effect of glucose
appears to be primarily mediated by insulin and is
coupled with insulin-induced NO-ergic vasodilation of
skeletal muscle arterioles [42, 43]. Interestingly, fructose,
as glucose, increases postprandial energy expenditure,
and this effect could be lowered by about 30 % using
beta-adrenergic antagonists [44]. However, glucose acti-
vates muscle sympathetic nerve activity while fructose
does not, suggesting that stimulation of adaptive thermo-
genesis by fructose is independent of insulin secretion
and does not involve muscle sympathetic nerve activa-
tion.
The effects of the sympathetic nervous system on car-
diovascular and hemodynamic functions are highly com-
plex and only partially elucidated. They involve the co-
ordinated activation of several subsets of sympathetic ner-
vous fibers, as was illustrated by studies on mental stress
[45, 46].Mental stress can be elicited in animals by forced
immobilization and in humans by complex experimental
paradigms reproducing what happens in a prey when en-
countering a predator. Activation of the sympathetic ner-
vous system altogether with stimulation of glucocorti-
coids and catecholamines from the adrenal medulla then
elicits a set of coordinated hemodynamic and metabolic
responses to allow for Bfight or flight^ responses (i.e.
aiming to immediately optimize muscle functions to out-
run the predator or eventually to fight for life). These
include increases in cardiac output and ventilation in or-
der to raise systemic blood flow and oxygenation.
Simultaneously, circulating substrates are raised follow-
ing the stimulation of hepatic glucose output and adipose
tissue lipolysis by glucocorticoids and sympathetic medi-
ators. Finally, muscle sympathetic nerve activation oc-
curs, inducing a local vasodilation that favors as a whole
Hypertension
Fructose
Overfeeding
Obesity
Hyperuricemia
Endothelial
dysfunction
Insulin resistance
Hyperinsulinemia
Insulin-induced
Na reabsorption
Increased
SNS activity
Fig. 2 Potential mechanisms linking dietary fructose and hypertension.
See text for detailed descriptions
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an increased delivery of oxygen and energy substrates to
skeletal muscle, ensuring optimal immediate response.
Food intake also elicits a set of integrated hemody-
namic adaptations to favor blood perfusion in digestive
organs at the expense of most other tissues excepting the
brain. SNS activation, again, is instrumental in many of
these effects, notably by increasing both heart rate and
contraction force, thus raising cardiac output [47]. Even
if digestive organs vasodilation is essentially produced by
local autoregulatory mechanisms, episodes of severe
postprandial systemic hypotension in individuals with au-
tonomic neuropathy indicate that SNS activation is still
required to maintain physiological blood pressure [48].
This is mainly attained by alpha-adrenergic vasoconstric-
tion of arterioles in non-digestive vascular beds in the
kidneys and the skin. Surprisingly, ingestion of a meal
is associated with sympathetic nerve activation altogether
with arteriolar vasodilation in skeletal muscle. This effect
appears mediated by insulin-induced release of nitric ox-
ide from muscle endothelium, possibly triggered by acti-
vation of sympathetic NO-ergic fibers. This unexpected
vasodilation in skeletal muscle induced bymeal ingestion
has also now been recognized to contribute to insulin
sensitivity by facilitating the delivery of both glucose
and insulin to skeletal muscle.
Acute administration of a fructose drink, but not of
glucose, produces a small and transient increase in systol-
ic and diastolic blood pressure in healthy humans [49].
This may indicate that fructose activates vasoconstrictive
sympathetic fibers in some non-digestive organs to a larg-
er extent than glucose and hence may favor the develop-
ment of hypertension is some individuals. This effect was
however observed with administration of pure fructose
only, but disappeared when glucose and fructose were
co-ingested due to glucose-induced, insulin-dependent
muscle vasodilation [50]. This therefore suggests that in-
gestion of fructose-containing sweeteners such as su-
crose, honey, and high-fructose corn syrup is unlikely to
produce large acute increases in blood pressure.
– Hyperuricemia
Intravenous infusion of large fructose loads has been
recognized since several decades to result in several met-
abolic perturbations including hyperlactatemia, hypogly-
cemia, and hyperuricemia [10]. The same effects can be
observed when subjects with hereditary fructose intoler-
ance ingest even small amounts of fructose or sorbitol.
This condition is due to an inherited deficiency of aldol-
ase B, with the consequence that fructose is phosphory-
lated to fructose-1-P in fructokinase-expressing cells, a
reaction which is associated with ATP consumption
[51]. The absence of aldolase B thereafter impairs further
metabolism of fructose-1-P and thus prevents ATP regen-
eration. This leads to ATP depletion and energy crisis in
fructokinase-expressing cells such as hepatocytes, in
which this impairs glucose production, thus leading to
hypoglycemia. In the kidneys, it leads to proximal tubular
dysfunction and acidosis. In addition, ATP depletion
stimulates the degradation of ADP to AMP and inositol,
thus increasing uric acid production [52]. It is likely that,
in normal subjects, the i.v. administration of large
amounts of fructose leads to a rapid phosphorylation of
fructose to fructose-1-phosphate, which outpaces tempo-
rarily the ability of aldolase B to clear fructose-1-phos-
phate. It results that i.v. administration of fructose is as-
sociated with an acute increase in blood uric acid and can
occasionally cause acute metabolic defects similar to
those encountered in hereditary fructose intolerance.
Administration of oral physiological fructose loads is
occasionally associated with moderate postprandial in-
creases in blood uric acid concentration, the latter effect
being however inconstant [53]. In contrast, an increase in
dietary fructose intake is associated with moderate, yet
highly significant elevations in fasting uric acid concen-
trations [53]. This effect is consistently observed in
hypercaloric, high-fructose diets when fructose iso-
energetically replaces starch or fat. This long-term mod-
erate hyperuricemia is unlikely to be explained by ATP
depletion, since it is not associated with the landmark
effects of energy crisis in liver cells (i.e., hypoglycemia)
or in renal tubules (i.e., proximal tubule dysfunction and
renal acidosis). Instead, most subjects with hyperuricemia
secondary to ingestion of a high-fructose diet present ev-
idence of increased hepatic glucose production and de
novo lipogenesis [54], two energy-requiring metabolic
processes unlikely to be active in ATP-depleted cells. In
turn, consumption of a high-fructose diet is almost invari-
ably associated with an increase in blood lactate concen-
trations [46], but this merely reflects a physiological con-
version of fructose into a more ubiquitously usable ener-
gy substrate, rather than a state of acidosis. Early isotope
studies indicated that fructose may stimulate the
endogenous synthesis of uric acid [55], but the exact
mechanism and functional significance of this remains
unknown. In turn, the study of kidneys transporter pro-
teins has dramatically progressed over the past decades
and provides additional putative mechanisms. Uric acid
and lactate share the same transporter in proximal tubule
cells, URAT1, and the high blood lactate concentrations
observed after fructose intake may compete with uric acid
filtration and decrease uric acid renal clearance (Fig. 3)
[56].
Interestingly, it has recently been documented that uric
acid may exert important regulatory effects in several
physiological processes [52]. Hyperuricemia potently ac-
tivates the NALP3 inflammasome (cryopyrin) [57] and
may therefore trigger a low-grade chronic inflammation
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secondarily responsible the development of insulin resis-
tance [58]. An increase in uric acid in the liver may stim-
ulate fructose metabolism [59•] and lipogenic enzymes
[60•] and may thus contribute to further enhance de novo
lipogenesis. High uric acid concentration may also impair
normal endothelial function and may contribute to the
development of hypertension or to that of insulin resis-
tance by preventing insulin-induced vasodilation [61].
The latter mechanisms have been reported in rodent
models of high-fructose diet, while human observations
were more mitigated. One study reported that middle-
aged, hypertensive, obese high-fructose consumers had
significantly reduced blood pressure when their blood
uric acid concentrations were lowered with administra-
tion of allopurinol [32]. However, this was not associated
with any improvement of markers of insulin resistance
such as glucose and insulin concentration nor of
dyslipidemia.
– Kidneys Dysfunction
The effects of dietary fructose on blood pressure re-
main altogether highly controversial. Fructose is associ-
ated with the development of hypertension in some, but
not all rat models fed a high-fructose diet. The explana-
tion responsible between studies differences remains
unknown, but other co-variables are likely to be involved.
Some investigators have suggested that hypertension
occurring in some high-fructose fed animals may be due
to some experimental artifacts such as diet copper [62] or
magnesium [63] deficiencies.
Of more importance, there is growing evidence that
fructose enhances the effects of a high-salt diet on blood
pressure [64••]. This may result from multiple effects of
fructose on renal handling of sodium and other ions.
Fructose has indeed been shown to increase the reabsorp-
tion of sodium in the proximal tubule through various
mechanisms, including enhanced bicarbonate reabsorp-
tion and increased sodium-hydrogen exchangers [65].
Major regulatory steps of sodium and water metabolism
linked to blood pressure control take place in the distal renal
tubule. Of interest, filtered glucose is normally completely
reabsorbed from the primary urine in the proximal tubule and
does not reach the distal renal tubule apart in overt diabetes
mellitus. Chronic hyperglycemia and glycosuria in diabetes
mellitus are associated with increased kidneys size and the
progressive development of renal and cardiovascular dys-
function. Compared to glucose, blood fructose concentra-
tions remain most of the time very low and can only tran-
siently reach 0.5–0.8 mmol L−1 following a fructose-
containing meal. Under such conditions, however, fructose
can be filtered by the kidneys and appears in primary urine.
In contrast to glucose, which can be efficiently reabsorbed in
the proximal tubule through an active sodium-glucose co-
transport, fructose is only removed from the proximal tubule
by passive diffusion. It seems thus conceivable that dietary
fructose can reach the distal parts of the nephron, where its
effects on renal function remain to be evaluated [66].
Epidemiological studies show an association between
sugar [24] and fructose [30] intake and the development of
hypertension or cardiovascular diseases, yet obesity is an
important confounder in these analyses. There is strong ev-
idence that a high sugar intake is frequently encountered in
obese subjects, and part of these associations may therefore
be related to excess body weight or insulin resistance. In
support of this hypothesis, insulin-resistant subjects have
chronically elevated hyperinsulinemia, which has been
shown to increase renal sodium reabsorption [67]. There is
also evidence that endothelial function is frequently im-
paired in insulin resistant subjects, possibly due to lipid-
mediated endothelial toxicity. Such endothelial dysfunction
have minimal effects on resting arterial pressure, but can be
associated with excessive blood pressure rise in response to
external stimuli such as stress [45, 46].
Conclusion
In a well-balanced analysis, Casazza and colleagues noticed that
Bpassionate interests, the human tendency to seek explanations
for observed phenomena, and everyday experience appear to
contribute to strong convictions about obesity^ [68]. In the con-
text of fructose research, these words of caution sound
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ATP Uric acid
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Fig. 3 Potential deleterious effects of fructose-induced hyperuricemia.
Fructose may increase plasma uric (i.e., hyperuricemia) acid through (1)
transient intrahepatocellular energy depletion (due to ATP consumption
by fructokinase following large i.v. fructose loads), (2) stimulation of
endogenous uric acid synthesis from purine and glycine precursors (by
unknown mechanisms), and (3) decreased uric acid excretion (by
competition with lactate for secretion into urinary tubules). In turn, hy-
peruricemia may contribute to the metabolic effects of fructose by
triggering inflammation through the NALP3 inflammasome or by
impairing endothelial function, in turn promoting insulin resistance and
hypertension. Hyperuricemia may also activate lipogenic enzymes (not
shown). ATP adenosine triphosphate, Fructose-1-P fructose-1-phosphate
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particularly pertinent, and many mechanisms still need to be
understood before reaching definitive conclusions. There is in-
deed a strong evidence that a high sugar intake is present inmany
obese patients, and that can be associated with the development
of non-communicable diseases. In our opinion, this is mostly
explained by the hedonic properties of sugary foods, which tend
to favor the overconsumption of highly palatable energy-dense
foods when available. Compared to other nutrients such as glu-
cose or fat, fructose is first processed in splanchnic organs and
then released as glucose, lactate, or VLDL-TG into the systemic
circulation. This may contribute to the development of and he-
patic insulin resistance during chronic excessive intake of both
total energy and sugar. Additional effects of fructose on blood
uric acid and sympathetic nervous system activity have also been
reported, but their link with metabolic and cardiovascular dis-
eases remains hypothetical. Interestingly, there is growing evi-
dence that more fructose may escape first pass hepatic liver me-
tabolism than previously thought, and that systemic low fructose
concentrations may exert important effects on kidney function.
Whether this is related to the development of high blood pres-
sure and cardiovascular diseases remains to be further assessed.
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